Abstract
ABSTRACT
Background
Short‐term outcomes following heart transplantation in children have improved, but comparable improvements in long‐term survival continues to have barriers. We sought to investigate long‐term outcomes following heart transplantation and to identify protective and risk factors associated with long‐term survival in children.
Methods
The Pediatric Heart Transplant Society (PHTS) database was queried for heart transplant recipients from 1993 to 2010 who were ≤ 10 years of age at time of transplant. Patients with conditional graft survival > 3 years and at ≥ 10 years were analyzed. Survival and time‐to‐event were compared using the Kaplan–Meier method with a log‐rank test for significance. Factors associated with graft loss were identified using Cox proportional hazard modeling.
Results
There were 1610 patients ≤ 10 year of age who were transplanted between 1993 and 2010 with conditional survival to 3 years post‐transplant. Of those patients, there were 1170 with conditional survival to 10 years post‐transplant. Patients < 1 year at transplant had improved survival compared to other age groups. Risk factors for graft loss after 3 years post‐transplant were malignancy, rejection, cardiac allograft vasculopathy (CAV), age, congenital heart disease, female sex, and Black race (p value for all < 0.05).
Conclusions
Heart transplantation remains an effective therapy in children with a growing number of long‐term survivors. Risk factors for mortality in patients ≤ 10 years of age at transplant with conditional survival to 3 years post‐transplant include CAV, rejection, malignancy, female sex, and Black race. Further studies are needed to understand the social and biologic causes of racial and sex disparities in pediatric transplant patients.
Heart transplantation remains an effective therapy in children with a growing number of long‐term survivors. Risk factors for mortality in patients ≤ 10 years of age at transplant with conditional survival to 3 years post‐transplant include CAV, rejection, malignancy, female sex, and Black race.